A Role of Serum Interleukin-39 and Association with Small and Non-Small Cell Carcinoma in Lung Cancer Patients
IL-39 shows promise as a predictive and diagnostic biomarker in lung cancer, particularly in small-cell carcinoma, and may play a protective role in disease modulation through immune-related pathways.
Authors
- Rola H. Ali (ORCID: https://orcid.org/0000-0001-5747-8900)
- Faiq F. Karam (ORCID: https://orcid.org/0000-0002-5753-9491)
- Hanaa Addai Ali (ORCID: https://orcid.org/0000-0002-9825-1494)
- Fatimah Swadi Zghair (ORCID: https://orcid.org/0000-0002-8871-0634)
- Lubna R. Al-Ameer
- Nidhal Hatif Hammood
- Mohauman Mohammed Alrufaie
- Muthana Saleh Mashkour
- Wisam Abdulameer Noman
Institutions
- University of Babylon (IQ)
- Green University of Bangladesh (BD)
- University of Al-Qadisiyah (IQ)
- Ministry of Higher Education and Scientific Research (IQ)
- University of Kerbala (IQ)
- Al-Zahraa University for Women
- University of Kufa (IQ)
Publication Details
- Journal
- Asian Pacific Journal of Cancer Prevention
- Published
- 2025-09-01
- DOI
- https://doi.org/10.31557/apjcp.2025.26.9.3299
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00